Evidence map›Paper›PMID 25496916›Full record

ArticleRetrovirology2014

A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1.

Min-Hsuan Lin, Haran Sivakumaran, Alun Jones, Dongsheng Li, Callista Harper, Ting Wei, Hongping Jin, Lina Rustanti, Frederic A Meunier, Kirsten Spann and 1 more

Abstract read
In one paragraph

Article in Retrovirology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.Microbiology and molecular biology reviews : MMBR · 2016
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Block and Lock HIV Cure Strategies to Control the Latent Reservoir.Frontiers in cellular and infection microbiology · 2020
    Review
  11. StrongmBio · 2019
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Min-Hsuan LinQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. min-hsuan.lin@qimrberghofer.edu.au.
Haran SivakumaranQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. haran.sivakumaran@qimrberghofer.edu.au.
Alun JonesInstitute for Molecular Bioscience, The University of Queensland, St. Lucia, Queensland, Australia. a.jones@imb.uq.edu.au.
Dongsheng LiQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. dongsheng.lin@qimrberghofer.edu.au.
Callista HarperQueensland Brain Institute, The University of Queensland, St. Lucia, Queensland, Australia. c.harper@uq.edu.au.
Ting WeiQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. ting.wei@qimrberghofer.edu.au.
Hongping JinQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. hongping.jin@qimrberghofer.edu.au.
Lina RustantiQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. lina.rustanti@qimrberghofer.edu.au.
Frederic A MeunierAustralian Infectious Disease Research Centre, The University of Queensland, St. Lucia, Queensland, Australia. f.meunier@uq.edu.au.
Kirsten SpannAustralian Infectious Disease Research Centre, The University of Queensland, St. Lucia, Queensland, Australia. k.spann@uq.edu.au.
David HarrichQIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. david.harrich@qimrberghofer.edu.au.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPreviously we described a transdominant negative mutant of the HIV-1 Tat protein, termed Nullbasic, that downregulated the steady state levels of unspliced and singly spliced viral mRNA, an activity caused by inhibition of HIV-1 Rev activity. Nullbasic also altered the subcellular localizations of Rev and other cellular proteins, including CRM1, B23 and C23 in a Rev-dependent manner, suggesting that Nullbasic may disrupt Rev function and trafficking by intervening with an unidentified component of the Rev nucleocytoplasmic transport complex.

resultsTo seek a possible mechanism that could explain how Nullbasic inhibits Rev activity, we used a proteomics approach to identify host cellular proteins that interact with Nullbasic. Forty-six Nullbasic-binding proteins were identified by mass spectrometry including the DEAD-box RNA helicase, DDX1. To determine the effect of DDX1 on Nullbasic-mediated Rev activity, we performed cell-based immunoprecipitation assays, Rev reporter assays and bio-layer interferometry (BLI) assays. Interaction between DDX1 and Nullbasic was observed by co-immunoprecipitation of Nullbasic with endogenous DDX1 from cell lysates. BLI assays showed a direct interaction between Nullbasic and DDX1. Nullbasic affected DDX1 subcellular distribution in a Rev-independent manner. Interestingly overexpression of DDX1 in cells not only restored Rev-dependent mRNA export and gene expression in a Rev reporter assay but also partly reversed Nullbasic-induced Rev subcellular mislocalization. Moreover, HIV-1 wild type Tat co-immunoprecipitated with DDX1 and overexpression of Tat could rescue the unspliced viral mRNA levels inhibited by Nullbasic in HIV-1 expressing cells.

conclusionsNullbasic was used to further define the complex mechanisms involved in the Rev-dependent nuclear export of the 9 kb and 4 kb viral RNAs. All together, these data indicate that DDX1 can be sequestered by Nullbasic leading to destabilization of the Rev nucleocytoplasmic transport complex and decreased levels of Rev-dependent viral transcripts. The outcomes support a role for DDX1 in maintenance of a Rev nuclear complex that transports viral RRE-containing mRNA to the cytoplasm. To our knowledge Nullbasic is the first anti-HIV protein that specifically targets the cellular protein DDX1 to block Rev's activity. Furthermore, our research raises the possibility that wild type Tat may play a previously unrecognized but very important role in Rev function.

Indexed as

Virus ReplicationCell LineDEAD-box RNA HelicasesHIV-1HumansImmunoprecipitationMass SpectrometryMutant ProteinsProtein Interaction MappingProteomicsrev Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency VirusDDX1 protein, humanDEAD-box RNA HelicasesMutant Proteinsrev Gene Products, Human Immunodeficiency Virustat Gene Products, Human Immunodeficiency Virus

Identifiers

PMID25496916
PMCPMC4271445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.